March 25, 2021 - MedVector has begun the rollout of its Prime-Control tm Technology, to give contract research organizations (CROs) and pharma sponsors access to patients without triggering new ...
Meeting: MedVector’s telehealth platform. One of the biggest obstacles facing pharmaceutical companies is the decade or more it can take to complete three phases of clinical trials required for ...
Craig Lipset, a clinical trials industry innovator and leader, has joined the MedVector team as a new board member and executive advisor. Lipset, current co-chair of the Decentralized Trials and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results